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Abstract
Background: To follow the impact of the 2009 influenza pandemic in Denmark, influenza surveillance was extended with a
system monitoring potentially influenza-associated hospitalisations.
Methodology/Principal Findings: National administrative data from 2004–2010 from the automatic reporting of all hospital
visits and admissions in Denmark (population 5.5 million) were used. In-patient hospitalisations linked to ICD-10 codes for
potentially influenza-associated conditions (influenza, viral and bacterial pneumonia, respiratory distress, and febrile
convulsion) were aggregated by week and age groups; ,5 years, 5–24 years, 25–64 years and $65 years. Weekly numbers
of influenza-associated hospitalisations were plotted to follow the course of the pandemic. We calculated the total numbers
of influenza-associated hospitalisations in each influenza season (week 30 to week 15, the following year). Risk ratios of
being admitted with an influenza-associated condition in this season (2009/2010) compared to the previous five seasons
(2004/2005–2008/2009) were calculated using binary regression. During the pandemic season, influenza-associated
hospitalisations peaked in week 47, 2009. The total number of influenza-associated hospitalisations was 38,273 compared to
the median of previous seasons of 35,662 (p=0.28). The risk ratio of influenza-associated hospitalisations during the
pandemic season compared to previous seasons was 1.63 (95%CI 1.49–1.78) for 5–24 year-olds and ranged between 0.98
and 1.08 for the other three age groups.
Conclusions: The 2009 pandemic influenza did not lead to an overall increase in the number of influenza-associated
hospitalisations in Denmark in the 2009/2010 season and could be managed within existing hospital capacity. However,
there was a disproportionally large impact on the age group 5–24 years. The influenza-associated hospitalisations during
the 2009/2010 pandemic influenza season bore the signature features of historical pandemics: A skewed age-pattern and
early out of season transmission.
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Introduction
The first case of the pandemic influenza A(H1N1) was
diagnosed in Denmark at the very beginning of May 2009. In
the weeks following, further cases were diagnosed throughout the
country. At that time four surveillance systems provided data for
risk assessment; the virological surveillance, the general practi-
tioner-based influenza sentinel surveillance system, the electronic
reporting from all on-call general practitioners and the all-cause
mortality monitoring [1–3].
Following the decision of the World Health Organization
(WHO) on the 11
th of June 2009 to declare phase 6 of the
pandemic [4], and in accordance with the Danish pandemic plan
[5], further steps were taken to enhance the influenza surveillance
in the country, including setting up a surveillance system for
potentially influenza-associated hospitalisations.
At the time of the emergence of the 2009 pandemic influenza
A(H1N1), some countries had established systems for monitoring
of influenza hospitalisations, such as the Emerging Infections
Programme (EIP) in the United States, which carried out
screening of hospital records for laboratory-confirmed cases
[6,7]. Other countries made the novel influenza a notifiable
disease at the beginning of the pandemic and employed these
notifications to monitor hospitalisations [8,9] and yet other
countries encouraged active reporting of laboratory-confirmed
hospital in-patients [10,11].
In Denmark, we were reluctant to add an active surveillance
system at the time of a mounting influenza epidemic and a mass-
vaccination campaign as it would cause additional strain to an
already burdened health-care system. Instead we chose to use
existing administrative data from the electronic reporting of all
hospital visits and admissions in the country, kept in the National
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which has previously not been used for influenza surveillance, we
extracted the data needed for this new surveillance system. The
aim was to monitor the hospitalisations for influenza-associated
conditions in order to describe the magnitude and age-pattern of
influenza-associated hospitalisations in the pandemic influenza
season and compare it to seasonal influenza years.
According to the established influenza surveillance systems in
Denmark, there was a first summer wave of pandemic influenza
transmission surrounding week 30 of 2009 and then a larger
autumn-winter wave starting in week 40, with a peak in week 47
[1]. Here we describe the findings from the surveillance system set
up to monitor influenza-associated hospitalisations during the
2009/2010 pandemic season.
Methods
Data source
Due to administrative reasons and in order to monitor the
utilization of the Danish health care system, all Danish hospitals
make electronic reporting to the Danish National Board of Health
of all patient visits and admissions to the hospital; including in-
patient hospitalisations, visits to out-patients’ clinics and visits to
Accident & Emergency wards. The reports are sent regularly, at
least monthly, and are assembled in the National Patient Registry.
This registry has undergone routine evaluation [12,13]. Each
record in the registry stores information on a hospital visit or
admission with the relevant dates, the civil registration number
(CPR-number) of the patient, the region of the hospital, the type of
hospital visit/admission and the ICD-10 diagnostic codes
(International Classification of Diseases, 10
th Revision) [14] linked
to the visit/admission as well as any interventions made [12]. In
essence, the registry holds information on all hospitalisations of
any of the 5.5 million inhabitants in Denmark.
Case definition
We selected groups of ICD-10 codes for potentially influenza-
associated diagnoses; influenza, viral and unspecified pneumonia
and bacterial pneumonia, which have all previously been used in
assessing influenza morbidity [15,16]. We added febrile convul-
sion, as it has been described to be triggered by influenza infection
in children [17] and acute respiratory distress, which at the start of
the pandemic was highlighted as a clinical presentation among
severe cases with the novel influenza [18]. Hence, some of the
conditions are known to be secondary to an influenza infection,
these were included in the surveillance system in order to reach a
high sensitivity. A list of all the selected ICD-10 codes can be
found in the appendix (Appendix S1).
Records of hospital visits/admissions stated as in-patient
hospitalisations, with either of the selected ICD-10 codes as a
primary or secondary diagnosis were extracted from the registry
and included in the analysis and will be referred to as influenza-
associated hospitalisations. A series of influenza-associated hospi-
talisations of the same patient were considered as one influenza-
associated episode if the admissions were within a six-week time
period. Admissions with a longer time interval were considered as
separate episodes. This assumption was also used when analysing
each diagnostic group separately; however, one hospitalisation
could be included in several of the diagnostic groups, had several
of the selected diagnoses been given.
Generally the age groups used by the European Influenza
Surveillance Network [19] are used for influenza surveillance in
Denmark. However, in consideration of early reports about the
pandemic influenza, we chose to widen the 5–14 years age group
to also include adolescents and young adults as these groups of the
population seemed to have a particularly severe disease [18,20].
Hence, the present surveillance system used the four age groups:
under five year-olds, 5 to 24 year-olds, 25 to 64 year-olds and 65
years and above.
Study period
Data from the National Patient Registry from January 2004 and
onwards were used. Traditionally the influenza season in the
northern hemisphere is regarded as week 40 until week 20 of the
following year. However, during the 2009 pandemic the
transmission of influenza started exceptionally early [1,2]. In
order to include the time period of transmission of the pandemic
influenza as well as the time of the peaks of seasonal influenza, we
defined the time period of interest as week 30 until week 15 of the
following year, for the 2009/2010 season as well as for the
previous five seasons.
Data analysis
The relevant hospitalisation records were aggregated, by week
of admission and by age group. Weekly numbers of influenza-
associated hospitalisations, overall and by age group, were plotted
over time from week 1 of 2004 and onwards. We fitted a baseline
to the pre-pandemic data (week 1, 2004 to week 17, 2009) using a
Poisson regression model with a cyclical component and a linear
trend and with correction for overdispersion (Serfling model) [21].
Since we wanted to look at the morbidity of the pandemic season
compared to seasonal influenza years we did not exclude previous
outbreaks or outliers and the baseline should be referred to as an
expected weekly number according to the data from previous
years. The weekly influenza-associated hospitalisation numbers
during the pandemic were continuously plotted and compared to
this baseline.
In order to assess the overall impact of the pandemic influenza
posed on the hospitals in Denmark, we calculated the total number
of influenza-associated hospitalisations in the pandemic season and
compared it to the previous five seasons (2004/2005 until 2008/
2009). The relative burden of influenza-associated hospitalisations
compared to previous seasons was estimated as risk ratios in a
binary regression adjusted for an optional underlying trend in
hospitalisations. Risk ratios were estimated by age groups of 5 year
intervals, the four original age groups and by each diagnostic
group, in order to investigate any differences between age groups
and to uncover if any signals were diluted in the overall estimate
by certain diagnostic groups.
We also calculated the cumulative incidence of influenza-
associated hospitalisations during the pandemic season for the 5
year interval age groups, using population registry data as of 1
st of
October 2009 (Statistics Denmark) [22].
Data management was carried out in SAS [23] and Stata10.
Data analysis was carried out in Stata10 [24]. The confidence level
was set to 95%.
Ethics statement
Individual records were used only when checking for inconsis-
tencies and duplicates, thereafter the data was aggregated and all
analyses were carried out on aggregated and anonymised data. All
data were stored in a password protected format. The surveillance
system was notified to the Danish Data Protection Agency (2008-
54-0474).
According to Danish Law ethical clearance is not needed for
entirely registry-based studies, such as this one. Consent from
patients for storing of information in the registry is not needed,
again according to Danish Law.
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The surveillance system for influenza-associated hospitalisations
showed a peak of hospitalisations for all age groups around week
47, 2009. In the youngest age group there was a second peak in
week 7 of 2010, both peaks in this age group exceeding the upper
95% confidence interval of the baseline level. For the 5–24 year-
olds there was a peak in week 46, with 170 hospitalisations,
corresponding to 5.19 times (95%CI: 3.99–6.75) the usual number
in that week. The influenza-associated hospitalisations of the 25–
64 year-olds peaked in week 48 above the upper 95% confidence
level of the baseline, whereas the hospitalisations of the group of 65
years and above stayed within the 95% confidence intervals of the
baseline (figure 1).
In the previous five seasons the influenza-associated hospital-
isations peaked between week 1 and week 13, with a median in
week 5.
The total number of influenza-associated hospitalisations during
the influenza pandemic was 38,273 compared to the median of the
previous five seasons of 35,662 (p-value 0.28) (table 1). The
majority of influenza-associated hospitalisations (20,699 of 38,273
(54.1%)) were seen in the oldest age group, 65 years and above.
For this eldest age group and for the children the total number of
influenza-associated hospitalisations in the pandemic season were
not significantly different from previous seasons at a 95%
confidence level, (under 5 years: 6,307 compared to 5,996,
p=0.06 and 65 years and above: 20,699 compared to 19,544,
p=0.70) (table 1). However, in the other two age groups the total
number of influenza-associated hospitalisations was significantly
higher in the pandemic season (5–24 year-olds: 1,923 compared to
1,456, p,0.01 and 25–64 year-olds: 9,344 compared to 8,635,
p=0.01) (table 1).
Influenza, bacterial pneumonia and acute respiratory distress
were diagnosed more often in the pandemic season, whereas the
overall number of hospitalisations due to viral pneumonia and
febrile convulsions did not differ significantly from previous
seasons (table 1).
The cumulative risk ratios of being admitted with an influenza-
associated condition in the pandemic season compared to previous
seasons were highest for the 5 year interval age groups between 5
and 24 years, with risk ratios between 1.35 and 1.81. Above 75
years of age, the risk of influenza-associated hospitalisations in the
pandemic season was lower than in previous seasons. Among the
remaining age groups; the young children and the adults, the risk
ratios spanned 0.95 to 1.39 (figure 2).
During the 2009/2010 influenza season the highest cumulative
incidence of influenza-associated hospitalisations was seen in the
under 5 year-olds (1,934 hospitalisations/100,000 population) and
the age groups above 65 years (ranging between 1,063 and 5,727
hospitalisations/ 100,000 population). The lowest incidence was
Figure 1. Time-series of weekly numbers of influenza-associated hospitalisations in 2004–2010, by age group, in Denmark. The
baseline with 95% upper confidence interval is fitted to the pre-pandemic data; week 1, 2004 until week 17, 2009. The peak week of the 2009
influenza pandemic, week 47 of 2009, is indicated with vertical lines.
doi:10.1371/journal.pone.0013939.g001
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population (figure 2).
Discussion
This low labour cost surveillance system based on a data source
with consistent data collection over the years did not pick up any
overall excess in influenza-associated hospitalisations during the
2009/2010 pandemic influenza season in Denmark. However,
there was a disproportionally large impact on the 5–24 year-olds.
The system detected a peak in influenza-associated hospitalisations
in this age group, coinciding in time with the second wave of
pandemic influenza transmission and unprecedented in size during
the previous five years. The total number of influenza-associated
hospitalisations in 5–24 year-olds was 1.63-fold higher in the
pandemic season than in the previous five seasons.
The majority of influenza-associated hospitalisations were seen
in the age group 65 years and above. As the total number of
influenza-associated hospitalisations in this age group during the
pandemic season was in line with that of the previous five seasons
and the absolute numbers of influenza-associated hospitalisations
of the particularly affected 5–24 year-old age group was small in
comparison; the overall number of influenza-associated hospital-
isations in Denmark during the pandemic season did not show a
statistically significant difference to previous seasons. Thus, the
pandemic did not cause a major strain on the Danish health-care
system as a whole, which is compatible with the experience from
the southern hemisphere [25]. It is also consistent with studies on
Table 1. Total numbers of influenza-associated hospitalisations in Denmark, seasons 2004/2005–2009/2010, by age groups and
diagnostic groups.
Pandemic season Seasons 2004/2005 - 2008/2009 Risk ratio
Number of
hospitalisations
Median number of
hospitalisations (Range)
Pandemic season
compared to previous
seasons (95%CI) p
All age groups 38273 35662 (32709–37272) 1.04 (0.97–1.12) 0.281
Influenza 1783 570 (423–731) 2.80 (1.75–4.50) 0.000
Viral pneumonia 24043 24876 (22953–25241) 0.99 (0.92–1.06) 0.699
Bacterial pneumonia 8067 6342 (5577–7188) 1.10 (1.02–1.20) 0.019
ARDS 6742 5136 (4283–5909) 1.07 (1.01–1.13) 0.025
Febrile convulsions 2568 2548 (2344–2736) 1.01 (0.95–1.08) 0.715
Under 5 years Total 6307 5996 (5483–6132) 1.08 (1.00–1.17) 0.063
Influenza 410 64 (30–165) 2.63 (0.89–7.81)
Viral pneumonia 3059 2926 (2779–3096) 1.07 (1.01–1.13)
Bacterial pneumonia 545 443 (391–509) 1.20 (0.94–1.52)
ARDS 400 368 (351–390) 1.07 (0.98–1.16)
Febrile convulsions 2401 2415 (2217–2594) 0.99 (0.93–1.06)
5–24 years Total 1923 1456 (1233–1520) 1.63 (1.49–1.78) 0.000
Influenza 526 120 (97–157) 3.83 (2.54–5.78)
Viral pneumonia 891 864 (707–918) 1.32 (1.18–1.47)
Bacterial pneumonia 328 300 (231–331) 1.43 (1.25–1.63)
ARDS 189 117 (100–142) 1.45 (1.23–1.72)
Febrile convulsions 153 114 (105–129) 1.45 (1.34–1.57)
25–64 years Total 9344 8635 (7856–8830) 1.07 (1.02–1.13) 0.007
Influenza 735 257 (198–287) 2.73 (2.15–3.45)
Viral pneumonia 5711 5838 (5524–6123) 1.00 (0.95–1.04)
Bacterial pneumonia 2292 1866 (1686–1956) 1.15 (1.10–1.20)
ARDS 1858 1458 (1212–1655) 1.06 (0.99–1.13)
Febrile convulsions 10 9 (6–11) 0.83 (0.74–0.94)
65 years and above Total 20699 19544 (17914–21283) 0.98 (0.90–1.07) 0.704
Influenza 112 122 (68–132) 1.17 (0.67–2.04)
Viral pneumonia 14382 14867 (13786–15553) 0.95 (0.87–1.04)
Bacterial pneumonia 4902 3679 (3148–4492) 1.05 (0.95–1.16)
ARDS 4295 3140 (2544–3747) 1.06 (1.00–1.12)
Febrile convulsions 4 5 (4–9) 0.86 (0.56–1.32)
Total numbers of influenza-associated hospitalisations in the pandemic season and the median and range of total numbers of influenza-associated hospitalisations in
the five previous seasons (week 30 to week 15, the following year), by age groups and diagnostic groups. The pandemic season was compared to previous seasons in a
binary regression adjusted for an optional underlying trend.
doi:10.1371/journal.pone.0013939.t001
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sentinel system, which did not show mortality or consultation rates
for influenza-like illness dramatically different from previous
seasons [2,26]. However, the peak in the pandemic season both
in the sentinel system and the influenza-associated hospitalisations
appeared approximately 11 weeks before the median peak week
for previous seasons.
In accordance with the situation in many other European
countries, influenza surveillance in Denmark previous to the
pandemic focused on mild cases with influenza-like illness
attending primary health care and fatal cases registered in the
all-cause mortality monitoring. The present surveillance system
added estimates for the number of hospital admissions potentially
linked to influenza. Monitoring this aspect of influenza morbidity
gives additional information for health-care planning and provides
one of the parameters necessary for assessment of the burden of
influenza illness. Unlike many other surveillance systems set up as
a response to the pandemic, this surveillance system used historical
data as reference which is one of its major strengths. This along
with access to data on the age of all cases made it possible to fully
explore the age pattern of influenza-associated hospitalisations
compared to previous seasons. A hospitalisations surveillance
system that had not explored each age group separately would
have failed to signal during this pandemic.
The pattern of moderate relative impact on the elderly and a
disproportionally large impact on school-children and young adults
was corroborated by the findings from the Danish influenza
surveillance system of active reporting from on-call general
practitioners [1]. This skewed age-pattern, as well as transmission
out of the season, have been two of the signature features of the first
waves of the influenza pandemics of the 20
th century [16,27–29]. The
mild or moderate impact on the elderly by pandemic influenza is
generally ascribed to protective immunity due to pre-existing
antibodies from contact with a similar virus previously in life [30,31].
The fact that we did not only look at laboratory-confirmed
cases, in contrast to the hospitalisation surveillance set up due to
the pandemic in other countries [8–11] but instead used the ICD-
10 codes given at the time of discharge, means that only a portion
of cases registered by our surveillance system will actually have
had pandemic influenza A(H1N1) and there might also be
laboratory-confirmed hospitalised cases that were not picked up
by the system as they were not given any of the included ICD-10
diagnoses. However, as our aim was to have a low labour cost
system to follow the impact of the pandemic on influenza-
associated hospitalisations and to alert when there was any
extraordinary activity in secondary health care potentially
associated with influenza, this system was well-suited and could
even pick up signals of an increased activity had laboratory-testing
of all influenza cases failed.
Since we suspected that influenza would become a diagnosis of
choice during the pandemic, we wanted to add a wider spectrum
of diagnoses to this system to counteract this bias. Thus, conditions
known to be secondary to influenza infections were also included
in the system, increasing the sensitivity. However, this could
possibly lead to a decrease in specificity as the surveillance system
could potentially falsely signal when there was an increase in other
causes of influenza-associated hospitalisations, e.g. respiratory
syncytial virus.
On this note,the M-formation(double-peak) in the weekly counts
of the influenza-associated hospitalisations of young children in the
pandemic season is a notable finding; this M-formation can also be
seen in the weekly counts of hospitalisations due to febrile
convulsions (data not shown). We believe this can be explained by
the early surge of pandemic influenza causing the first peak of
hospitalisations in the young children and the respiratory syncytial
virus (RSV) season causing the second peak around week 7 of 2010.
Laboratory data for RSV from the laboratory at Statens Serum
Institut confirms the timing of this second peak.
Figure 2. Cumulative incidence and risk ratios of influenza-associated hospitalisations during the 2009 influenza pandemic in
Denmark. The cumulative incidence (bars) of influenza-associated hospitalisations for week 30 of 2009 to week 15 of 2010, by 5-year age groups,
and the risk ratios (line) for influenza-associated hospitalisations in the pandemic season compared to the five previous seasons adjusted for an
optional underlying trend in hospitalisations. In the age range 5 to 49 years, the risk ratios of hospitalisations were significantly higher than in the
previous five seasons (estimates marked with diamonds).
doi:10.1371/journal.pone.0013939.g002
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associated hospitalisations during the 2009 influenza pandemic
measured in our system is generally higher than described in other
countries that used strictly laboratory-confirmed cases, also when
taking into account that these cover shorter time periods. In these
other systems the highest cumulative incidence was seen in the
under 5 year olds and the lowest in the elderly [8,9,11]. This
Danish surveillance system also showed a high incidence in young
children but an even higher incidence in the elderly. We suggest
that an age-bias in the specificity of the diagnoses selected for our
system could contribute to the observed age-pattern. The
diagnoses primarily seen in the elderly, such as pneumonia and
respiratory distress are less specific to influenza than the diagnoses
primarily seen in children. Further studies into which age-specific
diagnoses most accurately captures the behaviour of influenza
would be relevant. In addition, less laboratory testing of elderly
patients may give rise to an underestimation of the influenza
burden among senior citizens in general.
The main limitation to this surveillance system turned out to be
the delay in data delivery. The National Board of Health carried
out a reorganisation of the storage of their registries; this work
coincided with the slope of the autumn-winter wave of the
pandemic, leading to a considerable delay in the delivery of
updates of the registry to us. In addition, there appears to be up to
a month’s delay in the reporting to the registry, despite it using an
automated reporting system. Hence, the number of influenza-
associated hospitalisations in the current season could increase as
we receive updates of the registry. However, as our data cover the
peak of the pandemic with a 21-week margin, these updates should
not affect our estimates in any substantial way.
All things considered, this system provided comprehensive
syndromic surveillance data earlier than many other European
hospitalisation surveillance systems. It showed that the 2009
influenza A(H1N1) pandemic was mirrored by a rise in influenza-
associated hospitalisations in 5-24 year-olds. This increase was
observed before the usual influenza season and vastly exceeded the
number of hospitalisations seen in this age group in previous years.
However, because the elderly, who account for the majority of
influenza-associated hospitalisations, were not more affected by
the pandemic than by the seasonal influenza of previous years, the
absolute number of admissions was at a magnitude that could be
managed within the existing hospital capacity.
Supporting Information
Appendix S1 List of ICD-10 codes. ICD-10 codes selected as
potentially influenza-associated for the surveillance system of
influenza-associated hospitalisations in Denmark during the 2009
influenza pandemic.
Found at: doi:10.1371/journal.pone.0013939.s001 (0.02 MB
DOC)
Acknowledgments
We thank Steen Ethelberg and Kenn Schultz-Nielsen for assistance with
data management, Sabrina Bacci for invaluable support, Kimberly Bloom-
Feshbach and Annette Hartvig Christiansen for advice and inspiring
discussions and Bernadette Gergonne for statistical inspiration, all at the
Department of Epidemiology, Statens Serum Institut, Copenhagen.
We thank Sundhedsstyrelsen, the Danish National Board of Health,
Copenhagen for data delivery.
And finally we thank the EPIET Coordinator team, European
Programme for Intervention Epidemiology Training, European Centre
for Disease Prevention and Control (ECDC), Stockholm for advice.
Author Contributions
Conceived and designed the experiments: KW KM. Performed the
experiments: KW. Analyzed the data: KW JN. Contributed reagents/
materials/analysis tools: JN. Wrote the paper: KW KM.
References
1. Mølbak K, Glismann S Influenza epidemic update. EpiNews 49. Available:
http://www.ssi.dk/English/News/EPI-NEWS/,/media/Indhold/EN%20-
%20engelsk/EPI-NEWS/2009/pdf/EPI-NEWS%20-%202009%20-
%20No%2049.ashx.
2. Glismann S, Valentiner-Branth P, Mølbak K, Nielsen LP (2010) Influenza
season 2009–2010. EpiNews 23. Available: http://www.ssi.dk/English/News/
EPI-NEWS/2010/No%2023%20-%202010.aspx.
3. EURO MOMO (2010) ‘‘European monitoring of excess mortality for public
health action.’’ Accessed July 19. http://www.euromomo.eu.
4. Chan M (2010) ‘‘World now at the start of 2009 influenza pandemic.’’ Date of
publication June 11. http://www.who.int/mediacentre/news/statements/
2009/h1n1_pandemic_phase6_20090611/en/index.html.
5. Sundhedsstyrelsen (National Board of Health) (2006) Preparedness for pandemic
influenza.1st ed. Copenhagen: Sundhedsstyrelsen.
6. Centre for Disease Control and Prevention. (2010) ‘‘FluView.’’ Last modified
May 28. http://www.cdc.gov/flu/weekly/weeklyarchives2009-2010/weekly20.
htm.
7. Centre for Disease Control and Prevention. (2010) ‘‘Emerging Infections
Programs’’ Last modified January 20. http://www.cdc.gov/ncpdcid/deiss/eip/
index.html.
8. van ’t Klooster TM, Wielders CC, Donker T, Isken L, Meijer A, et al. (2010)
Surveillance of hospitalisations for 2009 pandemic influenza A(H1N1) in the
Netherlands, 5 June – 31 December 2009. Euro Surveill 15(2).Available: http://
www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19461.
9. Baker MG, Wilson N, Huang QS, Paine S, Lopez L, et al. (2009) Pandemic
influenza A(H1N1)v in New Zealand: the experience from April to August 2009.
Euro Surveill 14(34). Available: http://www.eurosurveillance.org/ViewArticle.
aspx?ArticleId=19319.
10. Cullen G, Martin J, O’Donnell J, Boland M, Canny M, et al. (2009) Surveillance
of the first 205 confirmed hospitalised cases of pandemic H1N1 influenza in
Ireland, 28 April - 3 October 2009. Euro Surveill 14(44).Available: http://www.
eurosurveillance.org/ViewArticle.aspx?ArticleId=19389.
11. New South Wales public health network (2009) Progression and impact of the
first winter wave of the 2009 pandemic H1N1 influenza in New South Wales,
Australia. Euro Surveill 14(42). Available: http://www.eurosurveillance.org/
ViewArticle.aspx?ArticleId=19365.
12. Sundhedsstyrelsen (National Board of Health) (2010) [National Patient Registry].
Accessed June 17. http://www.sst.dk/Indberetning%20og%20statistik/
Landspatientregisteret.aspx.
13. Nickelsen TN (2002) [Data validity and coverage in the Danish National Health
Registry. A literature review]. Ugeskr Laeg 164(1): 33–37.
14. World Health Organization (2010) ‘‘International Classification of Diseases
(ICD)’’ Accessed June 17. http://www.who.int/classifications/icd/en.
15. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, et al. (2004)
Influenza-associated hospitalizations in the United States. JAMA 292(11):
1333–1340.
16. Simonsen L, Fukuda K, Schonberger LB, Cox NJ (2000) The impact of
influenza epidemics on hospitalizations. J Infect Dis 181(3): 831–837.
17. Millichap JG, Millichap JJ (2006) Role of viral infections in the etiology of febrile
seizures. Pediatr Neurol 35(3): 165–172.
18. World Health Organization. (2009) New influenza A(H1N1) virus infections:
global surveillance summary, May 2009. Weekly epidemiological record 84:
173–179. Available: http://www.who.int/wer/2009/wer8420.pdf.
19. European Centre for Disease Prevention and Control. (2010) ‘‘Influenza
Surveillance Network (EISN)’’ Accessed June 24. http://www.ecdc.europa.eu/
en/activities/surveillance/eisn/pages/home.aspx. Accessed: 2010 Jun 24.
20. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, et al. (2009) Emergence
of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med
360(25): 2605–2615.
21. Serfling RE (1963) Methods for current statistical analysis of excess pneumonia-
influenza deaths. Public Health Rep 78(6): 494–506.
22. Danmarks Statistik (Statistics Denmark) (2010) [Population counts] Accessed
June 25. http://www.statistikbanken.dk/statbank5a/default.asp?w=1366.
23. SAS (2010) Copyright  2010 SAS Institute Inc. Available: http://www.sas.
com/Copyright.html.
24. Stata: Data Analysis and Statistical Software (2010) Copyright 1996–2010
StataCorp LP. Available: http://www.stata.com.
25. Baker M, Kelly H, Wilson N (2009) Pandemic H1N1 influenza lessons from the
southern hemisphere. Euro Surveill 14(42). Available: http://www.eurosurveillance.
org/ViewArticle.aspx?ArticleId=19370.
26. Mazick A, Gergonne B, Wuillaume F, Danis K, Vantarakis A, et al. (2010)
Higher all-cause mortality in children during autumn 2009 compared with the three
Influenza-Assoc. Hosp.
PLoS ONE | www.plosone.org 6 November 2010 | Volume 5 | Issue 11 | e13939previous years: pooled results from eight European countries. Euro Surveill 15(5).
Available: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19480.
27. Miller MA, Viboud C, Balinska M, Simonsen L (2009) The signature features of
influenza pandemics--implications for policy. N Engl J Med 360(25): 2595–2598.
28. Andreasen V, Viboud C, Simonsen L (2008) Epidemiologic characterization of
the 1918 influenza pandemic summer wave in Copenhagen: implications for
pandemic control strategies. J Infect Dis 197(2): 270–278.
29. Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, et al. (1998)
Pandemic versus epidemic influenza mortality: a pattern of changing age
distribution. J Infect Dis 178(1): 53–60.
30. Ikonen N, Strengell M, Kinnunen L, Osterlund P, Pirhonen J, et al. (2010) High
frequency of cross-reacting antibodies against 2009 pandemic influenza
A(H1N1) virus among the elderly in Finland. Euro Surveill 15(5). Available:
http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19478.
31. Ahmed R, Oldstone MBA, Palese P (2007) Protective immunity and
susceptibility to infectious diseases: lessons from the 1918 influenza pandemic.
Nat Immunol 8(11): 1188–1193.
Influenza-Assoc. Hosp.
PLoS ONE | www.plosone.org 7 November 2010 | Volume 5 | Issue 11 | e13939